Loading
companiesCompany
Biostar Pharmaceuticals
Biostar Pharmaceuticals in Chengdu developed utidelone, the epothilone chemotherapy approved in China in 2021 for advanced breast cancer.
Also called: Chengdu Biostar
Overview
Biostar Pharmaceuticals is a Chengdu biotechnology company built around genetically engineered epothilones. Its lead product utidelone was approved by the NMPA in March 2021 with capecitabine for recurrent or metastatic breast cancer after anthracyclines and taxanes; an oral formulation and trials in other tumours followed.
Headquarters
Chengdu, China, CN
Scorecard
All companies#227of 1244 companies, score 23
- approved products +6
- targets +2
- modalities +2
- regions +1
- registry trials +12
1 approved, 0 in phase 3, 0 earlier, 1 targets, 37 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
ApprovedEpothilone analogue, microtubule-stabilising cytotoxic chemotherapy
Utidelone is Biostar Pharmaceuticals' epothilone chemotherapy, approved in China in 2021 with capecitabine for advanced breast cancer after anthracyclines and taxanes.
Similar pages
- TrialUtidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
Shares Utidelone, Cytotoxic chemotherapy.
- TrialThe Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospec
Shares Utidelone, Cytotoxic chemotherapy.
- TrialComparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients
Shares Utidelone, Cytotoxic chemotherapy.
fronts
technologies
drugs
ApprovedEpothilone analogue, microtubule-stabilising cytotoxic chemotherapy
trials
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesPhase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid TumorsUtidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases